What is the appropriate tapering schedule for nightly trazodone 100 mg in a patient with unstable anxiety after increasing sertraline (Zoloft) from 50 mg to 100 mg for worsening depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Discontinue Trazodone Now That Sertraline Has Been Increased

Given your recent sertraline dose increase to 100 mg for worsening depression, you should discontinue the trazodone 100 mg rather than continue it, as the American Academy of Sleep Medicine guidelines explicitly recommend against using trazodone for insomnia treatment 1. The evidence shows trazodone lacks clinically significant efficacy for sleep while carrying risks that may outweigh benefits.

Why Stop Trazodone

The 2017 AASM guidelines provide a WEAK recommendation against trazodone for sleep onset or maintenance insomnia 1. The single quality study showed:

  • Sleep improvements fell below clinical significance thresholds
  • 75% of trazodone users experienced adverse events vs 65% on placebo
  • Headache occurred in 30% (vs 19% placebo) and somnolence in 23% (vs 8% placebo)
  • No meaningful benefit on sleep quality, total sleep time, or nighttime awakenings

More importantly, trazodone is not adequate treatment for your worsening depression 2. The guidelines note that low-dose sedating antidepressants "do not constitute adequate treatment of major depression for individuals with comorbid insomnia" 2.

Tapering Schedule for Trazodone 100 mg

Taper very slowly over 2-4 weeks minimum to avoid withdrawal symptoms:

  • Week 1-2: Reduce to 50 mg nightly
  • Week 3: Reduce to 25 mg nightly
  • Week 4: Discontinue completely

This gradual approach is critical because trazodone has a short 3-9 hour half-life 3, 4, and case reports document withdrawal symptoms even with gradual discontinuation 3. The short half-life means abrupt cessation causes noradrenergic rebound 3.

Allow Sertraline Time to Work

Your sertraline increase to 100 mg needs 4-6 weeks to reach full therapeutic effect for depression. The FDA label shows sertraline 50-200 mg demonstrated efficacy in multiple trials 5. At 100 mg, you're in the therapeutic range that should address both depression and any anxiety-related sleep disturbance.

If Sleep Remains Problematic After Trazodone Taper

First-line options if insomnia persists:

  • Cognitive behavioral therapy for insomnia (CBT-I) - most effective long-term approach 2
  • FDA-approved hypnotics if needed: eszopiclone 2-3 mg, zolpidem 10 mg, or zaleplon 10 mg 2
  • Low-dose doxepin (3-6 mg) has better evidence than trazodone for sleep maintenance 1

Critical Pitfalls to Avoid

  • Do not stop trazodone abruptly - the short half-life makes withdrawal more likely 3
  • Do not use alternate-day dosing during taper - this increases withdrawal risk 6
  • Do not continue trazodone long-term - it lacks evidence for chronic insomnia and has potential harms 1
  • Do not expect immediate sleep improvement from sertraline - allow the full 4-6 weeks for mood and anxiety improvement, which often resolves secondary insomnia

The evidence strongly supports discontinuing an ineffective medication (trazodone) while optimizing your evidence-based antidepressant therapy (sertraline) for the primary condition causing instability.

References

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Mechanisms of the development of trazodone withdrawal symptoms.

International clinical psychopharmacology, 1994

Research

Trazodone dosing regimen: experience with single daily administration.

The Journal of clinical psychiatry, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.